StonvexLoading…
StonvexCore line items from LX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | ¥8.58B | ¥9.53B | ¥8.39B | ¥6.39B |
Operating Income | ¥2.08B | ¥1.35B | ¥1.33B | ¥1.03B |
Net Income | ¥1.68B | ¥1.10B | ¥1.07B | ¥825.93M |
EPS (Diluted) | ¥4.72 | ¥3.24 | ¥3.17 | ¥2.21 |
Total Assets | ¥23.16B | ¥22.24B | ¥23.14B | ¥22.77B |
Total Liabilities | ¥11.21B | ¥11.50B | ¥13.43B | ¥14.12B |
Cash & Equivalents | ¥2.16B | ¥2.25B | ¥2.62B | ¥1.49B |
Free Cash Flow OCF − CapEx | ¥3.26B | ¥834.40M | ¥2.59B | ¥-91.54M |
Shares Outstanding | 355.09M | 339.26M | 359.82M | 392.76M |